Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy-Reference-Cited by-同舟云学术

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy

Published:2014-04-05 Issue:7 Volume:14 Page:1007-1017
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Rijavec Erika,Genova Carlo,Barletta Giulia,Burrafato Giovanni,Biello Federica,Dal Bello Maria Giovanna,Coco Simona,Truini Anna,Alama Angela,Boccardo Francesco,Grossi Francesco

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14712598.2014.907786

Reference49 articles.

1. Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer

2. Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium

3. Role of immunotherapy in the treatment of advanced non-small-cell lung cancer

4. Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer

5. Enhancement of Antitumor Immunity by CTLA-4 Blockade

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Recent Progress and Challenges in Clinical Translation of Nanomedicines in Diagnosis and Treatment of Lung Cancer;Current Drug Targets;2024-01

3. Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors;Frontiers in Immunology;2023-03-06

4. Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer;Journal of Cancer;2023

5. Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism;Cancer Immunology, Immunotherapy;2021-04-20